53 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
13 Feb 24
InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
7:34pm
representing a unique and innovative treatment approach compared to current options available to patients; cash runway into calendar 3Q 2024; next stages
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
of novel, cannabinoid-based and other pharmaceutical therapies to treat disease combined with innovative drug delivery systems;
The Executive has … , commercializing, producing and marketing novel, cannabinoid-based and other pharmaceutical therapies to treat disease combined with innovative drug
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
14 Nov 23
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
4:36pm
preclinical program targeting the treatment of Alzheimer’s disease, representing a unique and innovative treatment approach compared to current options … about: INM-901 represents a unique and innovative treatment approach compared to current options available to patients; cash runway into calendar 3Q
424B3
13ipwa9
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-10.1
nw3ybgnjyggr849j cu
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-99.1
7g9wswp8rhh4v
18 May 22
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
1:34pm
8-K
EX-99.1
y55kgg9dahsvlpyrayd
6 May 22
Regulation FD Disclosure
2:50pm
8-K
EX-99.1
jd1466ax nnxi6t41pdg
21 Apr 22
Regulation FD Disclosure
2:46pm
DEF 14A
ycjc8am8da2
28 Oct 21
Definitive proxy
3:07pm
10-K
79bo497f sz5iv31t0gc
24 Sep 21
Annual report
7:31am
424B3
j110opx0y76h5jm
22 Jul 21
Prospectus supplement
10:27am